换一批
换一批Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
作者：
Sabine,Kayser [1]
;
Richard F,Schlenk [2]
;
Delphine,Lebon [3]
;
Martin,Carre [4]
;
Katharina S,Götze [5]
;
Friedrich,Stölzel [6]
;
Ana,Berceanu [7]
;
Kerstin,Schäfer-Eckart [8]
;
Pierre,Peterlin [9]
;
Yosr,Hicheri [10]
;
Ramy,Rahme [11]
;
Emmanuel,Raffoux [11]
;
Fatiha,Chermat [11]
;
Stefan W,Krause [12]
;
Walter E,Aulitzky [13]
;
Sophie,Rigaudeau [14]
;
Richard,Noppeney [15]
;
Celine,Berthon [16]
;
Martin,Görner [17]
;
Edgar,Jost [18]
;
Philippe,Carassou [19]
;
Ulrich,Keller [20]
;
Corentin,Orvain [21]
;
Thorsten,Braun [22]
;
Colombe,Saillard [23]
;
Ali,Arar [24]
;
Volker,Kunzmann [25]
;
Mathieu,Wemeau [26]
;
Maike,De Wit [27]
;
Dirk,Niemann [28]
;
Caroline,Bonmati [29]
;
Carsten,Schwänen [30]
;
Julie,Abraham [31]
;
Ahmad,Aljijakli [32]
;
Stephanie,Haiat [33]
;
Alwin,Krämer [34]
;
Albrecht,Reichle [35]
;
Martina,Gnadler [36]
;
Christophe,Willekens [37]
;
Karsten,Spiekermann [38]
;
Wolfgang,Hiddemann [38]
;
Carsten,Müller-Tidow [39]
;
Christian,Thiede [6]
;
Christoph,Röllig [6]
;
Hubert,Serve [40]
;
Martin,Bornhäuser [6]
;
Claudia D,Baldus [41]
;
Eva,Lengfelder [42]
;
Pierre,Fenaux [11]
;
Uwe,Platzbecker [43]
;
Lionel,Adès [11]
作者单位：
Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg. sabine.kayser@medizin.uni-leipzig.de.
[1]
NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.
[2]
Service des Maladies du Sang GH Sud, Amiens.
[3]
5HCE Grenoble, Service d'Oncologie et Hématologie Pédiatrique, Grenoble.
[4]
Department of Medicine III, Technical University of Munich.
[5]
Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden, TU Dresden.
[6]
Service d'Hématologie du Pr. Cahn Hopital Jean Minjoz, Besancon.
[7]
Hospital Nord, Nurnberg.
[8]
Service d'Hématologie, Hotel Dieu Nantes.
[9]
Département d'Hématologie Clinique du Chu Saint Eloi Montpellier.
[10]
Hôpital Saint Louis, Université Paris Diderot, Paris.
[11]
Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen.
[12]
Robert-Bosch-Hospital, Stuttgart.
[13]
Service d'Hémato-Oncologie du Pr. Castaigne Hopital Andre Mignot le Chesnay.
[14]
University Hospital Essen.
[15]
Service des Maladies du Sang Chru, Hopital Claude Huriez, Lille.
[16]
Klinik für Hämatologie, Onkologie und Palliativmedizin, Klinikum Bielefeld Mitte.
[17]
University Hospital Aachen.
[18]
Service de Médecine interne, Hématologie du Pr. Christian Chr Metz Thionville, Hopital de Marcy, Metz.
[19]
Department of Hematology, Oncology and Tumor Immunology, Charité-University Medical Center, Campus Benjamin Franklin, Berlin.
[20]
Angers University Hospital, Maladies du Sang, Angers; Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukemia, FHU-GOAL, France; Université d'Angers, Inserm, CRCINA, Angers.
[21]
Hôpital Avicenne, Assistance Publique - Hôpitaux de Paris, Université Paris.
[22]
Hematology Department, Institut Paoli Calmettes, Marseille.
[23]
Service d' Oncologie Médicale Hopital de la Source, Orleans.
[24]
University Hospital of Würzburg.
[25]
Service d'Hématologie, Hopital v.Provo, Roubaix.
[26]
Vivantes Klinikum Neukölln, Berlin.
[27]
Gemeinschaftsklinikum Mittelrhein gGmbH, Koblenz.
[28]
Division of Hematology, Hôpital de Brabois, Centre Hospitalier Universitaire de Nancy, Nancy.
[29]
Klinikum Offenburg.
[30]
Service d' Hématologie, Thérapie Cellulaire du Pr. Bordessoule, Hopital Universitaire Dupuytren, Limoges.
[31]
Service d'Hématologie du Dr. Sutton Centre Hospitalier v. Dupouy, Argenteuil.
[32]
Service d'Hematologie Clinique, CH Sud Francilien, Corbeil Essonnes.
[33]
Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg; German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg.
[34]
Department of Medicine III - Hematology and Internal Oncology, University Hospital Regensburg, Regensburg.
[35]
St. Vincentius Kliniken, Abteilung für Hämatologie, Onkologie, Immunologie und Palliativmedizin, Karlsruhe.
[36]
Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM Unit 1170, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif.
[37]
Department of Medicine III, University Hospital, Ludwig-Maximilians University (LMU) Munich, Munich.
[38]
Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg.
[39]
Department of Internal Medicine II, University Hospital of Frankfurt Main.
[40]
Department of Internal Medicine II, University Hospital of Kiel.
[41]
Department of Hematology and Oncology, University Hospital Mannheim, Mannheim.
[42]
Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig.
[43]
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);人类(Humans);白血病, 早幼粒细胞, 急性(Leukemia, Promyelocytic, Acute);中年人(Middle Aged);前瞻性研究(Prospective Studies);缓解诱导(Remission Induction);危险性评估(Risk Assessment);治疗结果(Treatment Outcome);维甲酸(Tretinoin);青年人(Young Adult)
DOI
10.3324/haematol.2021.278722
PMID
34047178
发布时间
2022-05-31
- 浏览0
Haematologica
Haematologica
3100-3106页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
